Oxler Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Oxler Private Wealth's IBB Position: Q1 2026 in Review
Oxler Private Wealth increased its iShares Biotechnology ETF (IBB) stake by 0.13% in Q1 2026, buying an estimated $342 and bringing the position to 1,597 shares worth $270K. The position accounts for 0.08% of the portfolio, ranked #78.
Oxler Private Wealth first reported a position in IBB in Q4 2020 and has held it in 22 quarters since. The position peaked at $784K in Q3 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Oxler Private Wealth held 1,597 shares of iShares Biotechnology ETF worth $270K as of Q1 2026.
- Oxler Private Wealth bought 2 iShares Biotechnology ETF shares in Q1 2026, an estimated $342.
- iShares Biotechnology ETF made up 0.08% of Oxler Private Wealth's portfolio in Q1 2026, its #78 holding.
- Oxler Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
- Oxler Private Wealth's iShares Biotechnology ETF position peaked at $784K in Q3 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Oxler Private Wealth's 13F filing for Q1 2026, filed 28 Apr 2026.